P928: OCULAR ADVERSE EVENTS AND FUNCTIONAL IMPACT IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Syrigou, Rodanthi, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Manousou, Kyriaki, Kastritis, Efstathios, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430953/
http://dx.doi.org/10.1097/01.HS9.0000970616.80080.6b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430953/
http://dx.doi.org/10.1097/01.HS9.0000970616.80080.6b

Ejemplares similares